Favrille

We are a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a proprietary technology that enables us to efficiently develop and manufacture active immunotherapy products designed to stimulate a patient's own immune system to mount a specific and sustained response to disease. Our lead product candidate, FavId®, is an active immunotherapy for the treatment of B-cell non-Hodgkin's lymphoma. We completed enrollment in a pivotal Phase 3 clinical trial of FavId in January 2006. The randomized, double-blind, placebo-controlled registration trial is designed to evaluate FavId following Rituxan®, the current standard of care, for the treatment of follicular B-cell non-Hodgkin's lymphoma. We have a Special Protocol Assessment from the U.S. Food & Drug Administration (FDA) for our Phase 3 trial. FavId has also received Fast Track designation from the FDA. Analysis of the primary endpoint, time to disease progression, is expected during the fourth quarter of 2007. In addition to our pivotal Phase 3 trial, we have additional Phase 2 and Phase 2/3 clinical trials of FavId ongoing in other B-cell non-Hodgkin's lymphoma indications. We are also developing additional applications based upon our immunotherapy expertise and proprietary technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.

Contact Details: 10445 Pacific Center Court San Diego, California 92121 United States of America Tel: 858-526-8000 Fax: 858-597-7040 Email: hr@favrille.com WWW: www.favrille.com/

Loading...

Press Releases on Favrille:
New Report Just Published: World Multiple Myeloma Therapeutics Market Report	7th July, 2009	Reportlinker	NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Multiple Myeloma Therapeutics Market http://www.reportlinker.com/p0119496/World
MMR Information Systems, Inc. Receives Licensing Proposal Involving the Company's Anti-CD20 Antibodies	15th May, 2009	MMR Information Systems, Inc.	LOS ANGELES, May 15 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: MMRF) (the "Company"), which was known as Favrille, Inc. until it acquired its subsidiary
Latino Coalition Highlights Importance of Personal Health Records At Economic Summit	6th May, 2009	MMR Information Systems, Inc.	MyMedicalRecords Bilingual PHR Identified as Helping Bring Healthcare Equality to Latino Families LOS ANGELES, May 6 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: MMRF)
MyMedicalRecords, Inc. Stand-Alone Audited Financial Statements for the Period Ending December 31, 2008 to be Filed with the SEC Today, Monday, May 4, 2009	4th May, 2009	MMR Information Systems, Inc.	LOS ANGELES, May 4 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: MMRF), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "
MMR Information Systems, Inc. Announces Restructuring of Credit Facility With The RHL Group, Inc.	30th April, 2009	MMR Information Systems, Inc.	LOS ANGELES, April 30 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: MMRF), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively,

Favrille Clinical Trials:
Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Favrille (FVRL) Financial information Links from Barchart
FVRL Quote from from Barchart.com
FVRL Chart from from Barchart.com
FVRL Profile from from Barchart.com
FVRL Opinion from from Barchart.com
→View more Favrille finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 307 times since April 2007, the link to the organisation's website has been followed 54 times

Search for more companies in San Diego,

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Favrille